ORIGINAL RESEARCH
Published on 17 Sep 2025
Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1614702
- 527 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
3,944
Total downloads
18k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 11 Sep 2025
Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway
doi 10.3389/fimmu.2025.1612318
- 598 views
ORIGINAL RESEARCH
Published on 01 Sep 2025
Efficacy and safety of DEB-TACE combined with transarterial TQB2450 infusion and oral Anlotinib as first-line treatment in advanced hepatocellular carcinoma: a single-arm phase II study
doi 10.3389/fimmu.2025.1667785
- 962 views
ORIGINAL RESEARCH
Published on 27 Aug 2025
ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia
doi 10.3389/fonc.2025.1589053
- 1,552 views
CASE REPORT
Published on 15 Aug 2025
Safety and clinical efficacy of immune checkpoint inhibitors in pediatric hepatocellular carcinoma: a case report and review of the literature
doi 10.3389/fonc.2025.1576892
- 1,091 views
SYSTEMATIC REVIEW
Published on 24 Jul 2025
Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1586914
- 1,867 views
ORIGINAL RESEARCH
Published on 23 Jun 2025
The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma
doi 10.3389/fimmu.2025.1585956
- 1,154 views
ORIGINAL RESEARCH
Published on 12 Jun 2025
Targeting CD16A on NK cells and GPC3 in hepatocellular carcinoma: development and functional validation of a therapeutic bispecific antibody
doi 10.3389/fimmu.2025.1599764
- 2,321 views
- 1 citation
ORIGINAL RESEARCH
Published on 23 May 2025
Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma
doi 10.3389/fimmu.2025.1573098
- 1,809 views
- 1 citation
SYSTEMATIC REVIEW
Published on 21 May 2025
The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis
doi 10.3389/fimmu.2025.1573505
- 2,309 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: